444
Registered trials
175
Recruiting
241
Completed trials
196
Sponsors active
68
Research sites
Phase III:
286
Phase II/III:
29
Phase II:
79
Phase I/II:
9
Phase III/IV:
5
Phase IV:
12
Phase I:
11
Phase I (Other):
2
Phase I (FiH):
10
Other:
1
Oversight events in trials active here:
33 serious breaches
162 temporary halts
8 urgent safety measures
11 unexpected events
25 corrective measures
across 71 trials
View oversight register →
Top conditions
Non-small cell lung cancer
16
Amyotrophic lateral sclerosis
8
Non-small cell lung cancer metastatic
7
Crohn's disease
6
Ovarian cancer
6
Fallopian tube cancer
5
Ovarian epithelial cancer
5
Non-small cell lung cancer stage III
5
Pulmonary arterial hypertension
4
Idiopathic pulmonary fibrosis
4
Prostate cancer metastatic
4
Non-small cell lung cancer stage II
4
Top sponsors
Merck Sharp & Dohme LLC
58
AbbVie Deutschland GmbH & Co. KG
16
Bristol-Myers Squibb Services Unlimited Company
14
AstraZeneca AB
11
Cancer Trials Ireland
11
University College Dublin
11
Novartis Pharma AG
8
Takeda Development Center Americas Inc.
8
Celgene Corp.
7
Novo Nordisk A/S
7
Regeneron Pharmaceuticals Inc.
7
Boehringer Ingelheim Espana S.A.
6
Cities with most trials
All 18 cities →All trials — page 5
444 totalShowing 97–120 of 444 trials